E
ELIAS Animal Health
Medical biotechnology company advancing treatment of cancer
About ELIAS Animal Health
ELIAS Animal Health specializes in pioneering cancer immunotherapy for dogs, focusing on personalized T cell treatments to combat cancer. The company operates in the veterinary healthcare market, targeting pet owners and veterinary professionals who seek advanced cancer treatments for dogs. ELIAS Animal Health's business model revolves around developing and providing a unique treatment protocol that vaccinates dogs with their own cancer cells to produce an immune response. This is followed by extracting and activating T cells from the patient, which are then reinfused to attack the cancer cells. The company generates revenue through clinical trials, treatment services, and partnerships with veterinary clinics. By leveraging adoptive cell therapy, ELIAS Animal Health aims to offer an effective alternative to traditional chemotherapy and radiation treatments, minimizing side effects and improving the quality of life for canine cancer patients.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Apr 2024 | $10M | $40M | Undisclosed | ↗ |
| SEED✓Equity / VC | May 2017 | $710K | $2.8M | Undisclosed | — |
Growth signals
Latest recorded traffic for ELIAS Animal Health is 2.7K monthly website visits, down 15.6% over the last three months. ELIAS Animal Health's team declined 18.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
ELIAS Animal Health in the Lenexa ecosystem
The ELIAS Animal Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors2 additional known investors
Bionovus Innovations
Women's Capital Connection
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ELIAS Animal Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ELIAS Animal Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









